ELVN
Ticker
Enliven Therapeutics, Inc.
ELVN · Healthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…Enliven Therapeutics, Inc. (ELVN), in the Healthcare sector, has 32 disclosed filings on Paydirt over the trailing twelve months from 9 corporate insiders: 0 purchases and 32 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 17 and filed Sep 21. The most active filer was Joseph P Lyssikatos with 13 filings.
Add to watchlistFilings, ttm
32
0 buys · 32 sells
Traders, ttm
9
9 insiders
Volume, ttmiDollar value disclosed in the window
$75.5M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 17
Filed yesterday
ADViAverage daily dollar volume
$83.7M
market data
Share price · 12M
$61.01 (+206.3%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $83.0M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
JLRecent filings
Benjamin HohlSALE
CHIEF FINANCIAL OFFICER
$288K5,729 sh across 2 lots
Exec Sep 17
Filed Sep 21 · 5:23 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $146K
2,916 sh × $50.03
Exec Sep 17
Filed Sep 21 · 5:22 PM ET Benjamin HohlSALE CHIEF FINANCIAL OFFICER $270K
4,630 sh × $58.35
Exec Aug 17
Filed Aug 19 · 4:17 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $228K
3,900 sh × $58.37
Exec Aug 17
Filed Aug 19 · 4:16 PM ET Mika K DerynckSALE Director $9.6M
158,795 sh × $60.21
Exec Aug 4
Filed Aug 6 · 8:18 PM ET Benjamin HohlSALE CHIEF FINANCIAL OFFICER $275K
5,202 sh across 2 lots
Exec Jul 17
Filed Jul 21 · 5:24 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $225K
4,247 sh across 2 lots
Exec Jul 17
Filed Jul 21 · 5:23 PM ET Lori Anne KunkelSALE Director $505K
10,000 sh across 2 lots
Exec Jul 6
Filed Jul 8 · 5:15 PM ET Orbimed Advisors LlcSALE 10% owner $38.9M
858,646 sh across 3 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $114K
2,599 sh × $43.87
Exec Jun 17
Filed Jun 22 · 5:30 PM ET Benjamin HohlSALE CHIEF FINANCIAL OFFICER $149K
3,401 sh × $43.86
Exec Jun 17
Filed Jun 22 · 5:30 PM ET Orbimed Advisors LlcSALE 10% owner $12.7M
281,408 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET Lori Anne KunkelSALE Director $267K
7,779 sh × $34.28
Exec Jun 5
Filed Jun 9 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $137K
3,475 sh × $39.53
Exec May 18
Filed May 20 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $232K
4,860 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $1.4M
40,000 sh × $35.10
Exec Mar 25
Filed Mar 27 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $139K
5,000 sh × $27.76
Exec Mar 17
Filed Mar 19 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $1.2M
40,000 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET Benjamin HohlSALE CHIEF FINANCIAL OFFICER $296K
10,000 sh × $29.58
Exec Mar 6
Filed Mar 10 · 5:30 PM ET Helen Louise CollinsSALE CHIEF MEDICAL OFFICER $1.2M
45,000 sh × $26.17
Exec Feb 17
Filed Feb 19 · 5:30 PM ET Joseph P LyssikatosSALE CHIEF SCIENTIFIC OFFICER $145K
5,000 sh × $29.04
Exec Feb 6
Filed Feb 10 · 5:30 PM ET Joseph P LyssikatosSALE CHIEF SCIENTIFIC OFFICER $535K
20,000 sh across 2 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET Anish PatelSALE CHIEF OPERATING OFFICER $1.3M
48,057 sh × $27.98
Exec Jan 9
Filed Jan 13 · 5:30 PM ET Richard A. HeymanSALE Director $308K
12,300 sh across 2 lots
Exec Jan 8
Filed Jan 12 · 5:30 PM ET Joseph P LyssikatosSALE CHIEF SCIENTIFIC OFFICER $3.5M
132,500 sh across 4 lots
Exec Jan 8
Filed Jan 12 · 5:30 PM ET